"At Yuma Regional Medical Center Cancer Center you’ll find a team of dedicated physicians, access to clinical trials, complementary therapies and staff who are caring and compassionate."

During the past decade, Yuma Cancer Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 13 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yuma Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored and "Montreal Heart Institute" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yuma Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "DACIMA Software" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Yuma Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Breast Cancer" (4 trials), "HER2-negative Breast Cancer" (2 trials) and "Neutropenia" (2 trials). Many other conditions were trialed in "Yuma Cancer Center" in a lesser frequency.

Most popular intervention types in "Yuma Cancer Center" are "Drug" (19 trials), "Other" (9 trials), "Biological" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Docetaxel" (5 trials), "Abemaciclib" (2 trials), "Cyclophosphamide" (2 trials) and "anastrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yuma Cancer Center" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Yuma Cancer Center". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Yuma Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yuma Cancer Center, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".